A citation-based method for searching scientific literature

Antonio Palumbo, Sara Bringhen, Maria-Victoria Mateos, Alessandra Larocca, Thierry Facon, Shaji K Kumar, Massimo Offidani, Philip McCarthy, Andrea Evangelista, Sagar Lonial, Sonja Zweegman, Pellegrino Musto, Evangelos Terpos, Andrew Belch, Roman Hajek, Heinz Ludwig, A Keith Stewart, Philippe Moreau, Kenneth Anderson, Hermann Einsele, Brian G M Durie, Meletios A Dimopoulos, Ola Landgren, Jesus F San Miguel, Paul Richardson, Pieter Sonneveld, S Vincent Rajkumar. Blood 2015
Times Cited: 379







List of co-cited articles
685 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma.
Thierry Facon, Shaji Kumar, Torben Plesner, Robert Z Orlowski, Philippe Moreau, Nizar Bahlis, Supratik Basu, Hareth Nahi, Cyrille Hulin, Hang Quach,[...]. N Engl J Med 2019
346
31

Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma.
María-Victoria Mateos, Meletios A Dimopoulos, Michele Cavo, Kenshi Suzuki, Andrzej Jakubowiak, Stefan Knop, Chantal Doyen, Paulo Lucio, Zsolt Nagy, Polina Kaplan,[...]. N Engl J Med 2018
483
27

Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial.
Brian G M Durie, Antje Hoering, Muneer H Abidi, S Vincent Rajkumar, Joshua Epstein, Stephen P Kahanic, Mohan Thakuri, Frederic Reu, Christopher M Reynolds, Rachael Sexton,[...]. Lancet 2017
429
25

A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients.
Monika Engelhardt, Anne-Saskia Domm, Sandra Maria Dold, Gabriele Ihorst, Heike Reinhardt, Alexander Zober, Stefanie Hieke, Corine Baayen, Stefan Jürgen Müller, Hermann Einsele,[...]. Haematologica 2017
112
24

Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma.
Lotfi Benboubker, Meletios A Dimopoulos, Angela Dispenzieri, John Catalano, Andrew R Belch, Michele Cavo, Antonello Pinto, Katja Weisel, Heinz Ludwig, Nizar Bahlis,[...]. N Engl J Med 2014
512
23

Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.
Jesús F San Miguel, Rudolf Schlag, Nuriet K Khuageva, Meletios A Dimopoulos, Ofer Shpilberg, Martin Kropff, Ivan Spicka, Maria T Petrucci, Antonio Palumbo, Olga S Samoilova,[...]. N Engl J Med 2008
22

Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group.
Pieter Sonneveld, Hervé Avet-Loiseau, Sagar Lonial, Saad Usmani, David Siegel, Kenneth C Anderson, Wee-Joo Chng, Philippe Moreau, Michel Attal, Robert A Kyle,[...]. Blood 2016
399
22

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group.
Antonio Palumbo, Hervé Avet-Loiseau, Stefania Oliva, Henk M Lokhorst, Hartmut Goldschmidt, Laura Rosinol, Paul Richardson, Simona Caltagirone, Juan José Lahuerta, Thierry Facon,[...]. J Clin Oncol 2015
797
22

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma.
Shaji Kumar, Bruno Paiva, Kenneth C Anderson, Brian Durie, Ola Landgren, Philippe Moreau, Nikhil Munshi, Sagar Lonial, Joan Bladé, Maria-Victoria Mateos,[...]. Lancet Oncol 2016
950
20

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.
S Vincent Rajkumar, Meletios A Dimopoulos, Antonio Palumbo, Joan Blade, Giampaolo Merlini, María-Victoria Mateos, Shaji Kumar, Jens Hillengass, Efstathios Kastritis, Paul Richardson,[...]. Lancet Oncol 2014
19

International staging system for multiple myeloma.
Philip R Greipp, Jesus San Miguel, Brian G M Durie, John J Crowley, Bart Barlogie, Joan Bladé, Mario Boccadoro, J Anthony Child, Herve Avet-Loiseau, Robert A Kyle,[...]. J Clin Oncol 2005
18

A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial.
Thierry Facon, Meletios A Dimopoulos, Nathalie Meuleman, Andrew Belch, Mohamad Mohty, Wen-Ming Chen, Kihyun Kim, Elena Zamagni, Paula Rodriguez-Otero, William Renwick,[...]. Leukemia 2020
43
41

Geriatric assessment in multiple myeloma patients: validation of the International Myeloma Working Group (IMWG) score and comparison with other common comorbidity scores.
Monika Engelhardt, Sandra Maria Dold, Gabriele Ihorst, Alexander Zober, Mandy Möller, Heike Reinhardt, Stefanie Hieke, Martin Schumacher, Ralph Wäsch. Haematologica 2016
99
17

Frailty in older adults: evidence for a phenotype.
L P Fried, C M Tangen, J Walston, A B Newman, C Hirsch, J Gottdiener, T Seeman, R Tracy, W J Kop, G Burke,[...]. J Gerontol A Biol Sci Med Sci 2001
16

Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma.
Meletios A Dimopoulos, Albert Oriol, Hareth Nahi, Jesus San-Miguel, Nizar J Bahlis, Saad Z Usmani, Neil Rabin, Robert Z Orlowski, Mieczyslaw Komarnicki, Kenshi Suzuki,[...]. N Engl J Med 2016
810
16

Patient-centered practice in elderly myeloma patients: an overview and consensus from the European Myeloma Network (EMN).
Alessandra Larocca, Sandra Maria Dold, Sonja Zweegman, Evangelos Terpos, Ralph Wäsch, Mattia D'Agostino, Sophia Scheubeck, Hartmut Goldschmidt, Francesca Gay, Michele Cavo,[...]. Leukemia 2018
53
28

Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials.
Sara Bringhen, Maria Victoria Mateos, Sonja Zweegman, Alessandra Larocca, Antonietta Pia Falcone, Albert Oriol, Davide Rossi, Maide Cavalli, Pierre Wijermans, Roberto Ria,[...]. Haematologica 2013
141
15

Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma.
A Keith Stewart, S Vincent Rajkumar, Meletios A Dimopoulos, Tamás Masszi, Ivan Špička, Albert Oriol, Roman Hájek, Laura Rosiñol, David S Siegel, Georgi G Mihaylov,[...]. N Engl J Med 2015
834
15

Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
P Moreau, J San Miguel, P Sonneveld, M V Mateos, E Zamagni, H Avet-Loiseau, R Hajek, M A Dimopoulos, H Ludwig, H Einsele,[...]. Ann Oncol 2017
352
14

Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial.
Maria-Victoria Mateos, Michele Cavo, Joan Blade, Meletios A Dimopoulos, Kenshi Suzuki, Andrzej Jakubowiak, Stefan Knop, Chantal Doyen, Paulo Lucio, Zsolt Nagy,[...]. Lancet 2020
129
14

International uniform response criteria for multiple myeloma.
B G M Durie, J-L Harousseau, J S Miguel, J Bladé, B Barlogie, K Anderson, M Gertz, M Dimopoulos, J Westin, P Sonneveld,[...]. Leukemia 2006
13

Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients.
S K Kumar, A Dispenzieri, M Q Lacy, M A Gertz, F K Buadi, S Pandey, P Kapoor, D Dingli, S R Hayman, N Leung,[...]. Leukemia 2014
782
13

Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.
Philippe Moreau, Tamás Masszi, Norbert Grzasko, Nizar J Bahlis, Markus Hansson, Ludek Pour, Irwindeep Sandhu, Peter Ganly, Bartrum W Baker, Sharon R Jackson,[...]. N Engl J Med 2016
586
13

Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma.
Michel Attal, Valerie Lauwers-Cances, Cyrille Hulin, Xavier Leleu, Denis Caillot, Martine Escoffre, Bertrand Arnulf, Margaret Macro, Karim Belhadj, Laurent Garderet,[...]. N Engl J Med 2017
521
13

Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology.
Supriya G Mohile, William Dale, Mark R Somerfield, Mara A Schonberg, Cynthia M Boyd, Peggy S Burhenn, Beverly Canin, Harvey Jay Cohen, Holly M Holmes, Judith O Hopkins,[...]. J Clin Oncol 2018
388
12

Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma.
Antonio Palumbo, Asher Chanan-Khan, Katja Weisel, Ajay K Nooka, Tamas Masszi, Meral Beksac, Ivan Spicka, Vania Hungria, Markus Munder, Maria V Mateos,[...]. N Engl J Med 2016
810
12

Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma.
Thierry Facon, Meletios A Dimopoulos, Angela Dispenzieri, John V Catalano, Andrew Belch, Michele Cavo, Antonello Pinto, Katja Weisel, Heinz Ludwig, Nizar J Bahlis,[...]. Blood 2018
121
11

Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma.
Meletios A Dimopoulos, Dominik Dytfeld, Sebastian Grosicki, Philippe Moreau, Naoki Takezako, Mitsuo Hori, Xavier Leleu, Richard LeBlanc, Kenshi Suzuki, Marc S Raab,[...]. N Engl J Med 2018
216
11

A clinical prediction model for outcome and therapy delivery in transplant-ineligible patients with myeloma (UK Myeloma Research Alliance Risk Profile): a development and validation study.
Gordon Cook, Kara-Louise Royle, Charlotte Pawlyn, Anna Hockaday, Vallari Shah, Martin F Kaiser, Sarah R Brown, Walter M Gregory, J Anthony Child, Faith E Davies,[...]. Lancet Haematol 2019
35
31

The relative importance of factors predicting outcome for myeloma patients at different ages: results from 3894 patients in the Myeloma XI trial.
Charlotte Pawlyn, David Cairns, Martin Kaiser, Alina Striha, John Jones, Vallari Shah, Matthew Jenner, Mark Drayson, Roger Owen, Walter Gregory,[...]. Leukemia 2020
24
45

Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia.
Heidi D Klepin, Ann M Geiger, Janet A Tooze, Stephen B Kritchevsky, Jeff D Williamson, Timothy S Pardee, Leslie R Ellis, Bayard L Powell. Blood 2013
219
10

Multiple myeloma.
Antonio Palumbo, Kenneth Anderson. N Engl J Med 2011
10

Continuous lenalidomide treatment for newly diagnosed multiple myeloma.
Antonio Palumbo, Roman Hajek, Michel Delforge, Martin Kropff, Maria Teresa Petrucci, John Catalano, Heinz Gisslinger, Wiesław Wiktor-Jędrzejczak, Mamia Zodelava, Katja Weisel,[...]. N Engl J Med 2012
533
10

Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma.
Sagar Lonial, Meletios Dimopoulos, Antonio Palumbo, Darrell White, Sebastian Grosicki, Ivan Spicka, Adam Walter-Croneck, Philippe Moreau, Maria-Victoria Mateos, Hila Magen,[...]. N Engl J Med 2015
838
10

International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer.
Hans Wildiers, Pieter Heeren, Martine Puts, Eva Topinkova, Maryska L G Janssen-Heijnen, Martine Extermann, Claire Falandry, Andrew Artz, Etienne Brain, Giuseppe Colloca,[...]. J Clin Oncol 2014
775
10

Gait speed, grip strength, and clinical outcomes in older patients with hematologic malignancies.
Michael A Liu, Clark DuMontier, Anays Murillo, Tammy T Hshieh, Jonathan F Bean, Robert J Soiffer, Richard M Stone, Gregory A Abel, Jane A Driver. Blood 2019
60
16

Review of 1027 patients with newly diagnosed multiple myeloma.
Robert A Kyle, Morie A Gertz, Thomas E Witzig, John A Lust, Martha Q Lacy, Angela Dispenzieri, Rafael Fonseca, S Vincent Rajkumar, Janice R Offord, Dirk R Larson,[...]. Mayo Clin Proc 2003
10

Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study.
Philippe Moreau, Michel Attal, Cyrille Hulin, Bertrand Arnulf, Karim Belhadj, Lotfi Benboubker, Marie C Béné, Annemiek Broijl, Hélène Caillon, Denis Caillot,[...]. Lancet 2019
314
10

Elderly patients with multiple myeloma: towards a frailty approach?
Sonja Zweegman, Monika Engelhardt, Alessandra Larocca. Curr Opin Oncol 2017
46
19

Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG).
Martine Extermann, Matti Aapro, Roberto Bernabei, Harvey Jay Cohen, Jean-Pierre Droz, Stuart Lichtman, Vincent Mor, Silvio Monfardini, Lazzaro Repetto, Liv Sørbye,[...]. Crit Rev Oncol Hematol 2005
634
9

Interpreting clinical trial data in multiple myeloma: translating findings to the real-world setting.
Paul G Richardson, Jesus F San Miguel, Philippe Moreau, Roman Hajek, Meletios A Dimopoulos, Jacob P Laubach, Antonio Palumbo, Katarina Luptakova, Dorothy Romanus, Tomas Skacel,[...]. Blood Cancer J 2018
82
10

Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN).
Antonio Palumbo, Sara Bringhen, Heinz Ludwig, Meletios A Dimopoulos, Joan Bladé, Maria V Mateos, Laura Rosiñol, Mario Boccadoro, Michele Cavo, Henk Lokhorst,[...]. Blood 2011
229
9


Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial.
Graham H Jackson, Faith E Davies, Charlotte Pawlyn, David A Cairns, Alina Striha, Corinne Collett, Anna Hockaday, John R Jones, Bhuvan Kishore, Mamta Garg,[...]. Lancet Oncol 2019
129
9

Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma.
Ajai Chari, Dan T Vogl, Maria Gavriatopoulou, Ajay K Nooka, Andrew J Yee, Carol A Huff, Philippe Moreau, David Dingli, Craig Cole, Sagar Lonial,[...]. N Engl J Med 2019
182
9


Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial.
Peter M Voorhees, Jonathan L Kaufman, Jacob Laubach, Douglas W Sborov, Brandi Reeves, Cesar Rodriguez, Ajai Chari, Rebecca Silbermann, Luciano J Costa, Larry D Anderson,[...]. Blood 2020
124
9

Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial.
Edward A Stadtmauer, Marcelo C Pasquini, Beth Blackwell, Parameswaran Hari, Asad Bashey, Steven Devine, Yvonne Efebera, Siddharta Ganguly, Cristina Gasparetto, Nancy Geller,[...]. J Clin Oncol 2019
94
9

Defining the vulnerable patient with myeloma-a frailty position paper of the European Myeloma Network.
Gordon Cook, Alessandra Larocca, Thierry Facon, Sonja Zweegman, Monika Engelhardt. Leukemia 2020
15
60

Persistent overall survival benefit and no increased risk of second malignancies with bortezomib-melphalan-prednisone versus melphalan-prednisone in patients with previously untreated multiple myeloma.
Jesús F San Miguel, Rudolf Schlag, Nuriet K Khuageva, Meletios A Dimopoulos, Ofer Shpilberg, Martin Kropff, Ivan Spicka, Maria Teresa Petrucci, Antonio Palumbo, Olga S Samoilova,[...]. J Clin Oncol 2013
182
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.